Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ATP8A2P2 is a processed pseudogene related to the ATP8A2 gene, which encodes a P4-ATPase (“aminophospholipid translocase”) involved in phospholipid transport across membranes. Unlike its parent gene, ATP8A2P2 does not encode a functional protein. Pseudogenes generally arise from gene duplication or retrotransposition followed by the accumulation of disabling mutations, such as premature stop codons or frameshifts. While some pseudogenes regulate their parental genes through transcript-based mechanisms (e.g., as siRNAs or miRNA sponges), no evidence links ATP8A2P2 to such regulatory functions or disease relevance. It should not be considered a therapeutic target, and its inclusion in lists of drug targets or gene function databases is for informational or annotation purposes only. There is nothing to suggest ATP8A2P2 itself serves as a receptor, enzyme, transporter, or a therapeutic target of any kind. If ATP8A2P2 was referenced as a drug target, that would be an error.
Not applicable. As a pseudogene, ATP8A2P2 produces no protein product and has no known direct pharmacological mechanism.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATPase phospholipid transporting 8A2 pseudogene 2 (ATP8A2P2).